Doctor profile · Federal record
Dr. Stephen Verral, D.O.
Dermatology Physician (CMS: Dermatology) · Glens Falls, NY
- NPI 1821119124
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 24 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1 S Western Ave
Glens Falls, NY 128013304
(518) 745-5280
fax (518) 745-5284
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- October 28, 2022
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #243122-1
- Medicaid
- NY #02893323
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821119124. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,842
Distinct HCPCS
10
Medicare allowed
$286,175
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,753 | 350 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,078 | 939 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 574 | 461 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 488 | 428 | $108 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 209 | 199 | $123 | |
11102 |
Biopsy of related skin growth, first growth | 205 | 189 | $86 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 152 | 11 | $114 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 105 | 101 | $55 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 76 | 18 | $1 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 47 | 35 | $148 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 232. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$801
Transactions
44
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 11 | $265.56 | |
| ABBVIE INC. | 21 | $177.13 | |
| Arcutis Biotherapeutics, Inc. | 2 | $132.41 | |
| Novartis Pharmaceuticals Corporation | 3 | $73.38 | |
| UCB, Inc. | 2 | $48.75 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $36.08 | |
| Amgen Inc. | 1 | $24.98 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $22.74 | |
| Lilly USA, LLC | 1 | $20.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,520
Patients
766
Total drug cost
$410,221
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 350 | 169 | $7,203 |
| Clobetasol Propionate | Generic | 138 | 81 | $8,116 |
| Triamcinolone Acetonide | Generic | 134 | 87 | $2,642 |
| Mometasone Furoate | Generic | 131 | 97 | $3,180 |
| Metronidazole | Generic | 106 | 62 | $7,661 |
| Fluorouracil | Generic | 99 | 81 | $9,484 |
| Doxycycline Hyclate | Generic | 92 | 31 | $3,197 |
| Methotrexate (Methotrexate Sodium) | Brand | 75 | 15 | $2,521 |
| Otezla (Apremilast) | Brand | 75 | 11 | $351,647 |
| Halobetasol Propionate | Generic | 60 | 31 | $4,106 |
Frequently asked questions
What is Dr. Stephen Verral's medical specialty?
Dr. Stephen Verral practices Dermatology Physician in Glens Falls, NY.
Where does Dr. Stephen Verral practice?
Dr. Stephen Verral practices at 1 S Western Ave, Glens Falls, NY 128013304. Office phone: 5187455280.
What is Dr. Stephen Verral's NPI?
Dr. Stephen Verral's National Provider Identifier (NPI) is 1821119124, issued by NPPES.
Does Dr. Stephen Verral accept Medicare assignment?
Yes. Dr. Stephen Verral accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Verral commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.